Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 May 2025
A study led by researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and the Broad Institute of MIT and Harvard has uncovered critical insights into the biology of embryonal tumor with multilayered ...
Read Full NewsAI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, inconsistent or unavailable, a global survey...
The recent hantavirus outbreak underscores how urbanization, deforestation, and rodent reservoirs can converge to shape zoonotic risk.
Dr Maurie Markman discusses a PLCO trial analysis highlighting the stark association between consistent heavy drinking and increased colorectal cancer risk.
The short answer is yes. Dr F. Perry Wilson explains why he believes AI still has a role in radiology.
A medical oncologist seeks to use his computer science knowledge to make AI understandable to the medical community.
Dr Emil Lou breaks down practice-changing GI oncology data from ASCO 2026, including transformative survival updates in pancreatic and upper GI cancers.
As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.
1.
No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma
2.
Glioblastoma treatment breakthrough shows promise
3.
Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.
4.
A novel blood test may enable the early identification of common, fatal cancers.
5.
WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research
1.
What You Need to Know about Hairy Cell Leukemia: A Comprehensive Guide
2.
Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights
3.
Unlocking the Mystery of Glanzmann Thrombasthenia: A New Hope for Patients
4.
Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments
5.
LncRNAs in Cancer: Shaping Tumor Progression & Paving New Paths for Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
5.
Navigating the Complexities of Ph Negative ALL - Part VIII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge